These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27756161)

  • 1. Modeling the chronic lymphocytic leukemia microenvironment in vitro.
    Crassini K; Shen Y; Mulligan S; Giles Best O
    Leuk Lymphoma; 2017 Feb; 58(2):266-279. PubMed ID: 27756161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.
    Cols M; Barra CM; He B; Puga I; Xu W; Chiu A; Tam W; Knowles DM; Dillon SR; Leonard JP; Furman RR; Chen K; Cerutti A
    J Immunol; 2012 Jun; 188(12):6071-83. PubMed ID: 22593611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
    Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.
    van Attekum MHA; van Bruggen JAC; Slinger E; Lebre MC; Reinen E; Kersting S; Eldering E; Kater AP
    Haematologica; 2017 Dec; 102(12):2069-2076. PubMed ID: 28971904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL.
    Chen Y; Peubez C; Smith V; Xiong S; Kocsis-Fodor G; Kennedy B; Wagner S; Balotis C; Jayne S; Dyer MJS; Macip S
    J Cell Mol Med; 2019 Jan; 23(1):340-348. PubMed ID: 30353642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Liu PP; Liu J; Jiang WQ; Carew JS; Ogasawara MA; Pelicano H; Croce CM; Estrov Z; Xu RH; Keating MJ; Huang P
    Oncogene; 2016 Oct; 35(43):5663-5673. PubMed ID: 27065330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.
    Ramsay AD; Rodriguez-Justo M
    Br J Haematol; 2013 Jul; 162(1):15-24. PubMed ID: 23617880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions.
    Burger JA; Gandhi V
    Blood; 2009 Sep; 114(12):2560-1; author reply 2561-2. PubMed ID: 19762501
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition.
    Slinger E; Thijssen R; Kater AP; Eldering E
    Leukemia; 2017 Dec; 31(12):2601-2607. PubMed ID: 28462919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterization.
    Natoni A; O'Dwyer M; Santocanale C
    Methods Mol Biol; 2013; 986():217-26. PubMed ID: 23436415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.
    Herishanu Y; Katz BZ; Lipsky A; Wiestner A
    Hematol Oncol Clin North Am; 2013 Apr; 27(2):173-206. PubMed ID: 23561469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine.
    Crassini K; Stevenson WS; Mulligan SP; Best OG
    Leuk Lymphoma; 2015; 56(12):3407-17. PubMed ID: 25804768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor.
    Choi MY; Kashyap MK; Kumar D
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):40-53. PubMed ID: 27742071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
    Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
    Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.
    Valsecchi R; Coltella N; Belloni D; Ponente M; Ten Hacken E; Scielzo C; Scarfò L; Bertilaccio MT; Brambilla P; Lenti E; Martinelli Boneschi F; Brendolan A; Ferrero E; Ferrarini M; Ghia P; Tonon G; Ponzoni M; Caligaris-Cappio F; Bernardi R
    Blood; 2016 Apr; 127(16):1987-97. PubMed ID: 26825709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli.
    Martinelli S; Maffei R; Fiorcari S; Quadrelli C; Zucchini P; Benatti S; Potenza L; Luppi M; Marasca R
    Leuk Res; 2017 Mar; 54():17-24. PubMed ID: 28092772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
    Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
    Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
    Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.